FHTX EPS Estimates
Foghorn Therapeutics Inc.
$1.87
+$0.02(+1.08%)
36
Overall
40
Value
18
Tech
52
Quality
Market Cap
$109.86M
Volume
440.81K
52W Range
$1.79 - $7.61
Target Price
$5.00
FHTX EPS estimates: the consensus estimate for Foghorn Therapeutics Inc.'s current fiscal year is -$0.86 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
FHTX EPS Estimates
- EPS estimate, current quarter
- $-0.23
- EPS estimate, next quarter
- $-0.24
- EPS estimate, current year
- $-0.86
- EPS estimate, next year
- $-0.91
- EPS growth, 3-year
- +23.35%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.18 |
| 2024 | $-1.58 |
| 2023 | $-2.34 |
| 2022 | $-2.62 |
| 2021 | $-2.73 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FHTX | $1.87 | +1.1% | 440.81K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Foghorn Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW